Condition

Resectable Sarcoma

ClinicalTrials.gov condition label

Clinical trials4

Recruiting2

Common interventions15

Lead sponsors shown3

Clinical trials

4 shown

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal MetastasesNCT03965234 · 2020-07-16

Intravital Microscopy in Human Solid TumorsNCT03823144 · 2019-02-28

Osteosarcoma With Resectable Pulmonary Metastasis: A Retrospective StudyNCT04546243 · 2020-01-01

Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric PatientsNCT04213794 · 2019-11-08

Common interventions

CisplatinDRUG2 Biospecimen CollectionPROCEDURE1 Computed TomographyPROCEDURE1 Cytoreductive SurgeryPROCEDURE1 Diagnostic MicroscopyDEVICE1 DoxorubicinDRUG1 Fluorescein Sodium InjectionDRUG1 Hyperthermic Intraperitoneal ChemotherapyDRUG1 Isolated Chemotherapeutic Lung PerfusionPROCEDURE1 Magnetic Resonance ImagingPROCEDURE1 MetastasectomyPROCEDURE1 Positron Emission TomographyPROCEDURE1 radiotherapy groupRADIATION1 resection groupPROCEDURE1 Sodium ThiosulfateDRUG1

Leading sponsors

Mayo Clinic2 Peking University People's Hospital1 Roswell Park Cancer Institute1

Trial status mix

RECRUITING2

COMPLETED1

TERMINATED1

Phase mix

EARLY_PHASE11

NA1

PHASE11

PHASE21

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.